Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
JOURNAL OF AUTOIMMUNITY, cilt.106, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 106
- Basım Tarihi: 2020
- Doi Numarası: 10.1016/j.jaut.2019.102340
- Dergi Adı: JOURNAL OF AUTOIMMUNITY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Anahtar Kelimeler: Biomarker, SLE, Organ damage, Prognosis, Outcome, C-REACTIVE PROTEIN, ORGAN DAMAGE, INTERFERON-ALPHA, DISEASE-ACTIVITY, INDEX, EFFEROCYTOSIS, BINDING, POPULATION, MORTALITY, SEVERITY
- İstanbul Üniversitesi Adresli: Evet
Özet
Objective: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels were shown to reflect damage accrual in cases of systemic lupus erythematosus (SLE). Herein, we evaluated suPAR as a predictor of future organ damage in recent-onset SLE.